Trial intelligence / Profile preview

Oxidative stress and extracellular nucleosomes in critically ill patients with acute kidney failure treated with continuous renal replacement therapies

2016-004361-12Phase 4Active

Sponsor
Fernando Sánchez
Start
Feb 2017
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of heparin in acute kidney failure (AKF) (2 arms), sponsored by Fernando Sánchez. Primary endpoint: Length of renal replacement therapy. Started Feb 2017; status: active.

02

Drugs

heparin
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on 2016-004361-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004361-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call